Impact of minimal residual disease outcomes with ciltacabtagene autoleucel in cartitude-4: Oncologist treatment preferences in lenalidomide-refractory multiple myeloma
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Puja Aggarwal, Robert Bone, Blaise Nwotchouang, Nicholas Moffett, Solly Chedid, Muhamed Baljevic, Bruce Feinberg
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417008951
Cites:
Cited by:
Related to: